Figure 1

(A) Aldosterone reductase family 1 member B10 (AKR1B10) is expressed in the cytoplasm in laryngeal carcinoma tissues, and it is also expressed in individual nuclei. AKR1B10 was diffusely expressed in most laryngeal carcinoma cells. (B) AKR1B10 is expressed in the nuclei of cells in squamous epithelial tissue adjacent to the basal layer. (C) Low Ki-67 expression in laryngeal squamous cell carcinoma (LSCC). (D) High Ki-67 expression in LSCC. (E) Negative MTp53 expression in laryngeal carcinoma. (F) Positive MTp53 expression in laryngeal carcinoma. (G) Negative MMP2 expression in LSCC. (H) Positive MMP2 expression in LSCC.